Mezzion Pharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 19, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	2,782,915	924,369	1,153,908	347,646	1,932,235	1,563,338
Market Cap Growth	224.75%	-19.89%	231.92%	-82.01%	23.60%	-6.13%
Enterprise Value	2,769,214	891,105	1,093,258	314,521	1,903,261	1,542,499
Last Close Price	91600.00	30850.00	39000.00	13000.00	72366.67	58600.00
Forward PE	-	71.28	71.28	71.28	71.28	151.06
PS Ratio	351.84	107.34	36.38	11.31	72.49	54.60
PB Ratio	161.85	20.07	18.78	13.25	30.77	27.52
P/TBV Ratio	178.68	20.80	19.29	14.12	31.59	28.33
EV/Sales Ratio	-	103.48	34.47	10.24	71.41	53.87
Debt / Equity Ratio	0.29	0.04	0.04	0.04	0.07	0.09
Net Debt / Equity Ratio	-0.47	-0.59	-0.91	-1.19	-0.69	-0.77
Net Debt / EBITDA Ratio	1.20	2.02	4.33	1.45	2.84	7.22
Net Debt / FCF Ratio	1.56	1.42	4.85	2.44	2.80	5.40
Asset Turnover	0.10	0.10	0.43	0.45	0.33	0.43
Inventory Turnover	1.15	1.20	3.82	3.01	2.44	3.26
Quick Ratio	0.60	1.12	2.12	1.35	2.72	3.35
Current Ratio	0.88	1.57	2.51	1.76	3.47	3.91
Return on Equity (ROE)	-48.05%	-36.23%	-29.03%	-81.54%	-22.75%	-27.85%
Return on Assets (ROA)	-12.10%	-10.76%	-12.39%	-21.14%	-13.16%	-7.00%
Return on Invested Capital (ROIC)	-93.93%	-116.73%	-8454.47%	-321.28%	-103.59%	-83.31%
Return on Capital Employed (ROCE)	-40.80%	-30.20%	-23.20%	-83.50%	-25.70%	-12.50%
Earnings Yield	-1.26%	-2.11%	-1.10%	-10.44%	-0.70%	-0.89%
FCF Yield	-0.60%	-2.06%	-1.00%	-3.69%	-0.80%	-0.52%
Buyback Yield / Dilution	-1.06%	-5.62%	-5.63%	-0.17%	-2.63%	-0.11%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.